Interim Management Statement

British & American Investment Trust PLC Interim Management Statement - 3 months to 31 March 2014 To the members of British & American Investment Trust PLC This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose. This interim management statement relates to the period from 1 January 2014 to 31 March 2014, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified. Investment objective To invest predominantly in investment trusts and other leading UK quoted companies to achieve a balance of income and growth. Benchmark FTSE All-Share Index and FTSE 100 Index. Material developments On 30 April 2014 the company published its Annual Financial Report for the year ended 31 December 2013. The Annual Financial Report contained a proposed final ordinary dividend of 5.1p payable on 26 June 2014 to shareholders on the register at 16 May 2014 resulting in a total payment for the year of 7.8p per share. A dividend of 1.75p will be paid to preference shareholders on 26 June 2014 resulting in a total payment for the year of 3.5p per share. Twenty largest equity holdings at 31 March 2014 (group basis) % Geron Corporation 16.4 Rit Capital Partners 13.5 Dunedin Income Growth Trust 10.1 British Assets Trust 7.7 Prudential 7.6 St James's Place Global Equity 6.9 Biotime Conv Pref Stock 4.5 Biotime 4.0 Scottish & American Investment Company 3.6 Invesco Income Growth Trust 3.2 Alliance Trust 3.0 F&C Asset Management - 6.75% FRN Sub. Bonds 2026 2.4 Earthport 2.2 Shires Income 1.9 Merchants Trust 1.9 Royal & Sun Alliance Insurance Group - 7.375% Cum. Irr. Pref. £1 1.8 Rothschilds Continuation Finance - 9% Perp. Sub. Gtd. Loan Notes 1.8 Barclays - 9% PIB Capital Bonds 1.0 Jupiter Income Trust 0.8 Matrix Chatham EZT (unquoted) 0.6 Total 94.9 Sector allocation as at 31 March 2014 (group basis) % Investment Trusts (equities) 44.92 Biomedical - USA 15.68 Unit trusts 7.37 Life Assurance 7.26 Biotechnology - USA 3.87 Software and computer services 2.67 Support services 0.32 Other Financial 0.31 Telecommunications 0.28 Leisure and hotels 0.15 Pharmaceuticals and healthcare 0.13 Overseas 0.10 Financial services 0.06 Preference shares 6.64 Derivatives - traded options 4.19 Fixed Interest Stocks 3.99 Permanent interest bearing 1.16 Property Units (unquoted) 0.83 Fixed Interest Stocks (unquoted) 0.07 Total 100.00 Key facts Performance As at As at As at As at As at 31 March 31 March 31 March 31 March 31 March 2014 2014 2013 2011 2009 Year to 1 year 3 years 5 years date Total assets (000) £26,340 Short term borrowings (000) £2,579 Actual gearing 9.79 % NAV (p) 75.3 FTSE All-Share 3,555.00 Share price (p) 90.0 -15.5% 16.9% 20.0% 57.9% Premium/(discount) 19.5% 4.5% -20.4% -24.8% Dividend yield 8.67% 9.87% 9.60% 11.58% Total expense ratio (year ended 31/12/13) 2.26% As at 31 March 2014: 1 year 3 years 5 years Value of £100 invested (dividends reinvested) 128.0 159.9 248.7 FTSE ALL-Share 108.8 128.8 213.3 Total Return; Net Income Reinvested, GBP Source: Walker Crips Stockbrokers Limited and Fundamental Data Limited. Source: Association of Investment Companies and Morningstar The Board is not aware of any significant events or transactions which have occurred between 31 March 2014 and the date of publication of this interim management statement which would have a material impact on the financial position of the Company. For latest performance information, please refer to the Company's website, www.baitgroup.co.uk. For British & American Investment Trust PLC 12 May 2014
UK 100

Latest directors dealings